C07K 14/811
Serine protease inhibitors
Official title: {Serine protease (E.C. 3.4.21) inhibitors}
C07K14/811 (Serine protease inhibitors) appears on 1,179 US grants and 1,316 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,179
- Published applications
- 1,316
- Assignees
- 714
- Inventors
- 2,704
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 4 | 0 |
| 1988 | 8 | 0 |
| 1989 | 8 | 0 |
| 1990 | 10 | 0 |
| 1991 | 9 | 0 |
| 1992 | 22 | 0 |
| 1993 | 24 | 0 |
| 1994 | 23 | 0 |
| 1995 | 30 | 0 |
| 1996 | 31 | 0 |
| 1997 | 38 | 0 |
| 1998 | 58 | 0 |
| 1999 | 62 | 0 |
| 2000 | 40 | 0 |
| 2001 | 46 | 10 |
| 2002 | 32 | 73 |
| 2003 | 35 | 129 |
| 2004 | 22 | 56 |
| 2005 | 38 | 59 |
| 2006 | 50 | 49 |
| 2007 | 34 | 38 |
| 2008 | 15 | 41 |
| 2009 | 21 | 47 |
| 2010 | 24 | 42 |
| 2011 | 19 | 44 |
| 2012 | 26 | 35 |
| 2013 | 21 | 44 |
| 2014 | 27 | 50 |
| 2015 | 35 | 47 |
| 2016 | 32 | 44 |
| 2017 | 33 | 68 |
| 2018 | 37 | 34 |
| 2019 | 42 | 42 |
| 2020 | 34 | 61 |
| 2021 | 34 | 63 |
| 2022 | 29 | 65 |
| 2023 | 24 | 52 |
| 2024 | 25 | 58 |
| 2025 | 30 | 37 |
| 2026 | 14 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Neutrophil elastase binding peptides and compositions thereof29 Sep 2026US 12,747,280 B2Case Western Reserve University
- Expression of the human lekti gene from the chromosome of Staphylococcus epidermidis29 Sep 2026US 12,747,281 B2Azitra Inc
- Ulinastatin polypeptides8 Sep 2026US 12,729,233 B2DiaMedica USA Inc.
- Vectors encoding a glucose-6-phosphatase (G6PASE-A) for gene therapy1 Sep 2026US 12,723,263 B2Genethon
- Application of MmPI in preparation of trypsin inhibitors30 Jun 2026US 12,668,618 B2Shaanxi University of Technology
- Methods and materials for treating gastrointestinal disorders27 Aug 2026US 2026/0248863 A1Mayo Foundation for Medical Education and Research
- Serine proteinase inhibitors: serp-1 and serp-1 rcl-derived peptides effect on microbiome composition and uses thereof27 Aug 2026US 2026/0248876 A1Arizona Board of Regents on behalf of Arizona State University
- Gene-edited natural killer cells27 Aug 2026US 2026/0250634 A1Crispr Therapeutics AG
- Compositions and methods for prevention and treatment of genetic disease20 Aug 2026US 2026/0240889 A1Children's Medical Center Corporation
- Antivirus proteins having a kringle 5 subunit20 Aug 2026US 2026/0242447 A1Creative BioTherapeutics
Most cited
By later US patents
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Viruses expressing chimeric binding proteins1,136US 5,403,484 AProtein Engineering Corporation · 1995
- Directed evolution of novel binding proteins1,057US 5,571,698 AProtein Engineering Corporation · 1996
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Anti-angiogenic compositions and methods of use413US 5,886,026 AAngiotech Pharmaceuticals, Inc. · 1999